97 related articles for article (PubMed ID: 9363954)
1. Novel therapies to prevent diabetic retinopathy.
Skolnick AA
JAMA; 1997 Nov; 278(18):1480-1. PubMed ID: 9363954
[No Abstract] [Full Text] [Related]
2. [Potential pharmacological treatments for diabetic retinopathy].
Watanabe D; Takagi H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():244-9. PubMed ID: 15999714
[No Abstract] [Full Text] [Related]
3. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
Yatoh S; Mizutani M; Yokoo T; Kozawa T; Sone H; Toyoshima H; Suzuki S; Shimano H; Kawakami Y; Okuda Y; Yamada N
Diabetes Metab Res Rev; 2006; 22(1):38-45. PubMed ID: 15892182
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology in development and progression of diabetic retinopathy].
Funatsu H; Yamashita H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():162-6. PubMed ID: 12430223
[No Abstract] [Full Text] [Related]
5. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
Okamoto T; Yamagishi S; Inagaki Y; Amano S; Koga K; Abe R; Takeuchi M; Ohno S; Yoshimura A; Makita Z
FASEB J; 2002 Dec; 16(14):1928-30. PubMed ID: 12368225
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
7. Blocking angiogenesis in diabetic retinopathy.
Bonn D
Lancet; 1996 Aug; 348(9027):604. PubMed ID: 8815360
[No Abstract] [Full Text] [Related]
8. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
9. [PKC 412].
Lansiaux A; Fabbro D; Meyer T; Hamy F; Bailly C
Bull Cancer; 1999; 86(7-8):614-7. PubMed ID: 10477377
[No Abstract] [Full Text] [Related]
10. [Aminoguanidine].
Kawano M; Kawakami M
Nihon Rinsho; 1997 Nov; 55 Suppl():221-4. PubMed ID: 9434471
[No Abstract] [Full Text] [Related]
11. [Development of therapeutic agents for diabetic neuropathies].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():614-21. PubMed ID: 15999780
[No Abstract] [Full Text] [Related]
12. Anti-angiogenic therapy of proliferative diabetic retinopathy.
Danis RP; Ciulla TA; Criswell M; Pratt L
Expert Opin Pharmacother; 2001 Mar; 2(3):395-407. PubMed ID: 11336594
[TBL] [Abstract][Full Text] [Related]
13. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
[TBL] [Abstract][Full Text] [Related]
14. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
Kaji Y; Oshika T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
[No Abstract] [Full Text] [Related]
15. Retinopathy and tissue hexose in drug-treated animals.
Engerman RL; Kern TS
Arch Ophthalmol; 1998 Apr; 116(4):543-4. PubMed ID: 9565062
[No Abstract] [Full Text] [Related]
16. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells.
Sone H; Deo BK; Kumagai AK
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1876-84. PubMed ID: 10845612
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and treatment of diabetic neuropathy].
Uesaka Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():256-9. PubMed ID: 12430238
[No Abstract] [Full Text] [Related]
18. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.
Aiello LP; Cahill MT; Cavallerano JD
Eye (Lond); 2004 Feb; 18(2):117-25. PubMed ID: 14762400
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
